From promise to practice: towards the realisation of AI-informed mental health care

N Koutsouleris, TU Hauser, V Skvortsova… - The Lancet Digital …, 2022 - thelancet.com
In this Series paper, we explore the promises and challenges of artificial intelligence (AI)-
based precision medicine tools in mental health care from clinical, ethical, and regulatory …

[HTML][HTML] Increasing diversity in clinical trials: overcoming critical barriers

LT Clark, L Watkins, IL Piña, M Elmer… - Current problems in …, 2019 - Elsevier
Clinical trial results provide the critical evidence base for evaluating the safety and efficacy
of new medicines and medical products. Efficacy and safety may differ among population …

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label …

CC Butler, FDR Hobbs, OA Gbinigie, NM Rahman… - The Lancet, 2023 - thelancet.com
Background The safety, effectiveness, and cost-effectiveness of molnupiravir, an oral
antiviral medication for SARS-CoV-2, has not been established in vaccinated patients in the …

[PDF][PDF] Improving representation in clinical trials and research

K Bibbins-Domingo, A Helman - 2022 - ncbi.nlm.nih.gov
The year the issues in this report, Improving Representation in Clinical Tri als and Research,
became urgent for me was 2017. I was then chair of the US Preventive Services Task Force …

Addressing racial and phenotypic bias in human neuroscience methods

EK Webb, JA Etter, JA Kwasa - Nature Neuroscience, 2022 - nature.com
Despite their premise of objectivity, neuroscience tools for physiological data collection,
such as electroencephalography and functional near-infrared spectroscopy, introduce racial …

“When offered to participate”: a systematic review and meta-analysis of patient agreement to participate in cancer clinical trials

JM Unger, DL Hershman, C Till… - JNCI: Journal of the …, 2021 - academic.oup.com
Background Patient participation in clinical trials is vital for knowledge advancement and
outcomes improvement. Few adult cancer patients participate in trials. Although patient …

Diversity and inclusion for the All of Us research program: A sco** review

BM Mapes, CS Foster, SV Kusnoor, MI Epelbaum… - PloS one, 2020 - journals.plos.org
The All of Us Research Program (All of Us) is a national effort to accelerate health research
by exploring the relationship between lifestyle, environment, and genetics. It is set to …

Disparities by race and ethnicity among adults recruited for a preclinical Alzheimer disease trial

R Raman, YT Quiroz, O Langford, J Choi… - JAMA Network …, 2021 - jamanetwork.com
Importance Underrepresentation of many racial/ethnic groups in Alzheimer disease (AD)
clinical trials limits generalizability of results and hinders opportunities to examine potential …

Diversity in clinical and biomedical research: a promise yet to be fulfilled

SS Oh, J Galanter, N Thakur, M Pino-Yanes… - PLoS …, 2015 - journals.plos.org
Diversity in Clinical and Biomedical Research: A Promise Yet to Be Fulfilled | PLOS Medicine
Skip to main content Advertisement PLOS Medicine Browse Current Issue Journal Archive …

Reaching the hard-to-reach: a systematic review of strategies for improving health and medical research with socially disadvantaged groups

B Bonevski, M Randell, C Paul, K Chapman… - BMC medical research …, 2014 - Springer
Background This study aims to review the literature regarding the barriers to sampling,
recruitment, participation, and retention of members of socioeconomically disadvantaged …